Smith & Nephew Plc
21 January 2004
SMITH & NEPHEW TO HOLD ANALYST BRIEFING AT THE AMERICAN ACADEMY OF ORTHOPAEDIC
SURGEONS MEETING
21 January 2004
Smith & Nephew plc will hold a meeting for analysts and investors at the
American Academy of Orthopaedic Surgeons (AAOS) on 10 March 2004 at 8.00am at
the Westin St Francis Hotel in San Francisco. The presentation, which will be
audio webcast live on the Smith & Nephew website, will focus on the products
being exhibited by the orthopaedic and endoscopy businesses at the surgeon
meeting, the largest orthopaedic congress in the world. The analysts meeting
will be hosted by Dave Illingworth, President of Smith & Nephew's orthopaedics
business, and Jim Taylor, President of the endoscopy business.
About Us
Smith & Nephew (LSE: SN, NYSE:SNN) is one of the world's leading medical devices
companies, specialising in Orthopaedics, Endoscopy and Advanced Wound
Management. Smith & Nephew ranks as the global leader in arthroscopy and
advanced wound management and is the fastest growing full-line orthopaedics
company in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeon and
healthcare professional customers, with whom its name is synonymous with the
highest standards of performance, innovation and trust. The company has 7,000
employees and operates in 32 countries around the world, generating sales of
over £1 billion.
Enquiries:
Smith & Nephew
Peter Nind Tel: +44 (0)20 7401 7646
Corporate Affairs Manager
Financial Dynamics - London
David Yates Tel: +44 (0)20 7831 3113
Financial Dynamics - New York
Deborah Ardern-Jones Tel: 001 212 850 5626
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.